
Opinion|Videos|January 23, 2026
How Pneumococcal Vaccine Efficacy Is Measured and Affirmed
Author(s)Jeff Goad, PharmD, MPH, APH
Fact checked by: Ron Panarotti
Explore how pneumococcal vaccine efficacy is measured, its real-world impact, and the importance of immunobridging for informed vaccination decisions.
Advertisement
This segment breaks down how pneumococcal vaccine efficacy and effectiveness are measured and why these distinctions matter when interpreting clinical trial data and real-world outcomes. It also explores the role of immunobridging in the approval of newer pneumococcal conjugate vaccines, key clinical end points used to evaluate vaccine performance, and what serotype differences mean for patient protection. Together, these insights help pharmacists translate evidence into informed, patient-centered vaccination decisions.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
2
Pharmacist Care Gets BP Patients to Goal Faster, Safer
3
Higher Pulmonary Microplastic Burden Observed in Patients With Lung Cancer
4
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
5

































































































